ReC

Mission

ReC Bioengineering Laboratories has been established on June 2023 by researchers with decades of experience in the design of devices for the detection of biopotentials (in particular HD-sEMG), related processing, and interpretation. ReC is committed with the design, development, manufacturing, and commercialization of innovative medical devices for the assessment of the neuromuscular system through High-Density surface Electromyograms (HD-sEMG).

The company has a strong research-oriented focus, grounding its activity on the leading technological and scientific experience of the Laboratory for Engineering of the Neuromuscular System (LISiN), Politecnico di Torino, Turin, Italy.

Establishing new collaborations and cooperating with leading experts, scientists, and researchers with the ultimate goal of advancing the knowledge on the neuromuscular system, are the pillars upon which ReC has been conceived.